Manufacturers can secure market access by focusing on patient experience, digital solutions, and data-driven technologies and contribute to a more patient-centered, value-driven healthcare ecosystem.
Fremont, CA: The pharmaceutical industry is set to undergo significant changes in market access strategies, necessitating innovative therapy approaches and technological advancements to successfully navigate the complex market landscape. Here are a few market access trends we’ll watch closely in the New Year.
PBMS Are Poised To Move Beyond Rebates
Pharmacy benefit managers (PBMs) increasingly recognize their potential in a dynamic healthcare landscape. Manufacturers can engage with PBMs through outcome-based collaborations, data-driven solutions, cost-effective treatment options, patient-centric solutions, innovative pricing models, and contract optimization, enhancing medication adherence and performance.
Complex Distribution Networks
Emerging pharma companies must adopt a strategic distribution approach that combines technological innovations, regulatory compliance, and patient-centric focus. They can collaborate with third-party logistics providers to focus on core competencies and leverage established distribution partners. Adopting adaptive supply chain strategies, such as dual sourcing, strategic stockpiling, and scenario planning, can help mitigate potential risks and disruptions in the distribution network.
